ArticleFrontiers in medicine2026

Treatment response and survival outcomes with BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a retrospective study.

Yufen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.